Drug intelligence / Profile preview

PODS BMP-2

Development stage
Preclinical
Lead developer
Cell Guidance Systems
Modality
Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Administration
Local Injection, Implantation, Intraarticular
01

Overview

PODS BMP-2 is a sustained-release crystalline protein formulation in which human bone morphogenetic protein-2 (BMP-2) is co-crystallized with the polyhedrin scaffold protein using the PODS (Polyhedrin Delivery System) technology. In this system, BMP-2 is expressed in insect cells together with polyhedrin, which self-assembles into microcrystals that entrap the nascent, natively folded BMP-2, protecting it from proteolytic degradation and enabling prolonged, protease-dependent release of active growth factor in vitro and in vivo.[1][4] Once liberated from the crystals, BMP-2 functions as a dimeric member of the TGF-β superfamily that binds type I and type II BMP receptors and signals via SMAD pathways to potently induce osteoblast and chondrocyte differentiation and promote bone and cartilage formation, with additional roles in cardiac development and epicardial cell migration.[1][4][6] PODS BMP-2 is currently supplied for research use, including applications in cartilage repair and osteoarthritis models where it has been shown to enhance chondrocyte proliferation, extracellular matrix production, and cartilage regeneration compared with conventional soluble BMP-2.

Other names
PODS Human BMP-2PODS BMP2PODS Bone morphogenic protein-2pBMP-2pBMP2pBMP 2
02

Targets

BMPR1ABMPR1BBMPR2 (Bone morphogenetic protein receptor type II)

Beyond the preview

Go deeper on PODS BMP-2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PODS BMP-2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call